98 related articles for article (PubMed ID: 26747465)
1. Numbers game: Researchers explore whether fewer than 3 doses of HPV vaccine are effective.
Cancer; 2016 Jan; 122(1):11-2. PubMed ID: 26747465
[No Abstract] [Full Text] [Related]
2. Three doses of HPV vaccine still recommended, for now.
BMJ; 2013 Apr; 346():f2797. PubMed ID: 23637199
[No Abstract] [Full Text] [Related]
3. Gardasil 9--a broader HPV vaccine.
Med Lett Drugs Ther; 2015 Mar; 57(1465):47-8. PubMed ID: 25853579
[No Abstract] [Full Text] [Related]
4. Recommendations of the Polish Society of HPV Infections Prophylaxis - (PS-HPVIP) (Polskie towarzystwo profilaktyki zakazen HPV - PTPZ-HPV) concerning the use of preventive vaccines against HPV.
Majewski S; Wysocki J; Sikorski M; Niemiec T; Jackowska T;
Med Wieku Rozwoj; 2008; 12(2 Pt 1):621-5, 627-31. PubMed ID: 19301511
[No Abstract] [Full Text] [Related]
5. HPV vaccine and males: issues and challenges.
Zimet GD; Rosenthal SL
Gynecol Oncol; 2010 May; 117(2 Suppl):S26-31. PubMed ID: 20129653
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with completion of the human papillomavirus vaccine series.
Neubrand TP; Breitkopf CR; Rupp R; Breitkopf D; Rosenthal SL
Clin Pediatr (Phila); 2009 Nov; 48(9):966-9. PubMed ID: 19483128
[No Abstract] [Full Text] [Related]
7. Design of a large outcome trial for a multivalent human papillomavirus L1 virus-like particle vaccine.
Luxembourg A; Bautista O; Moeller E; Ritter M; Chen J
Contemp Clin Trials; 2015 May; 42():18-25. PubMed ID: 25749310
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
[TBL] [Abstract][Full Text] [Related]
9. Age of recipient and number of doses differentially impact human B and T cell immune memory responses to HPV vaccination.
Smolen KK; Gelinas L; Franzen L; Dobson S; Dawar M; Ogilvie G; Krajden M; Fortuno ES; Kollmann TR
Vaccine; 2012 May; 30(24):3572-9. PubMed ID: 22469863
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccine: widening the scope for cancer prevention.
No JH; Kim MK; Jeon YT; Kim YB; Song YS
Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
[TBL] [Abstract][Full Text] [Related]
11. Practical implementation of HPV vaccines in clinical practice.
Kimmel SR
J Fam Pract; 2006 Nov; Suppl():18-22. PubMed ID: 17366754
[TBL] [Abstract][Full Text] [Related]
12. HPV vaccine protects at multiple sites, even for some previously exposed.
Printz C
Cancer; 2015 Sep; 121(17):2863. PubMed ID: 26291437
[No Abstract] [Full Text] [Related]
13. HPV: a danger at any age.
Avitzur O
Consum Rep; 2012 Feb; 77(2):12. PubMed ID: 22368798
[No Abstract] [Full Text] [Related]
14. HPV vaccines: what remains to be done? Interview by Lauren Constable.
Zur Hausen H
Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949
[No Abstract] [Full Text] [Related]
15. Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 Years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose.
Lamontagne DS; Thiem VD; Huong VM; Tang Y; Neuzil KM
J Infect Dis; 2013 Oct; 208(8):1325-34. PubMed ID: 23901077
[TBL] [Abstract][Full Text] [Related]
16. GARDASIL: prophylactic human papillomavirus vaccine development--from bench top to bed-side.
Shi L; Sings HL; Bryan JT; Wang B; Wang Y; Mach H; Kosinski M; Washabaugh MW; Sitrin R; Barr E
Clin Pharmacol Ther; 2007 Feb; 81(2):259-64. PubMed ID: 17259949
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccine uptake among males 11-26 years in United States: findings from the National Health and Nutrition Examination Survey, 2011-2012.
Pierre-Victor D; Mukherjee S; Bahelah R; Madhivanan P
Vaccine; 2014 Nov; 32(49):6655-8. PubMed ID: 25446825
[TBL] [Abstract][Full Text] [Related]
18. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
Dunne EF; Datta SD; E Markowitz L
Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccines: an update for gynecologists.
Ault KA
Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in Uganda.
LaMontagne DS; Mugisha E; Pan Y; Kumakech E; Ssemaganda A; Kemp TJ; Cover J; Pinto LA; Safaeian M
Vaccine; 2014 Oct; 32(47):6303-11. PubMed ID: 25218297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
